A newly established anti-interleukin-2 receptor beta chain (P75) monoclonal antibody inhibits the induction of allo-specific cytotoxic lymphocytes in combination with anti-interleukin-2 receptor alpha chain (P55) monoclonal antibody.
Niguma
T
T
First Department of Surgery, Okayama University Medical School, Japan.
Sakagami
K
K
Orita
K
K
D000911:Antibodies, Monoclonal / Q000276:immunology*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007165:Immunosuppression Therapy; D007700:Kinetics; D046911:Macromolecular Substances; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D046911:Macromolecular Substances; D015375:Receptors, Interleukin-2